| Literature DB >> 30705943 |
Hidenori Tanaka1, Shiro Oka2, Shinji Tanaka1, Katsuaki Inagaki2, Yuki Okamoto2, Kenta Matsumoto2, Kazuki Boda2, Ken Yamashita2, Kyoku Sumimoto2, Yuki Ninomiya1, Nana Hayashi1, Kazuaki Chayama2.
Abstract
Background and study aims The PCF-H290TI/L produced by Olympus is a novel colonoscope equipped with some advantageous features for endoscopic treatment. It is expected to improve the potential for retroflexion and overall endoscope operability, which can reduce the difficulty of performing colorectal ESD. The aim of this study was to evaluate the utility of the novel colonoscope in colorectal ESD. Methods Three hundred and forty-eight consecutive colorectal lesions resected via ESD between June 2014 and January 2017 at Hiroshima University Hospital were included in the retroflexion ability analysis. We compared the retroflexion potential of PCF-H290TI to that of a conventional endoscope. Two hundred and twenty-seven colorectal lesions located in the left-sided colon and resected with ESD between April 2009 and February 2018 were enrolled in the treatment outcome analysis. Treatment outcomes using PCF-H290TI compared to those of the conventional colonoscope, and outcomes of the PCF-H290TI with retroflexion compared to those of the conventional colonoscope without retroflexion were evaluated by propensity score matching. Results The retroflexion rate with the PCF-H290TI was 76 %, which was significantly higher than the 44 % rate with the conventional scope. Endoscope operability was better and dissection speed was faster when using the PCF-H290TI with retroflexion compared to the conventional colonoscope without retroflexion. There were no significant differences between the groups in en bloc resection rate and adverse events. Conclusion Compared to the conventional colonoscope, the PCF-H290TI/L made it easier to perform ESD via a retrograde approach regardless of tumor location, and thus may be useful for performing colorectal ESD.Entities:
Year: 2019 PMID: 30705943 PMCID: PMC6336463 DOI: 10.1055/a-0810-0567
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Flowchart of the treatment outcome analysis.
Retroflexion rates using the PCF-H290TI versus the conventional scope.
| Location | PCF-H290TI | Conventional scope |
| |
| Colonoscope | Gastroscope | |||
| Total | 117/154 (76) | 86/194 (44) | < .0001 | |
| Cecum, n = 50 | 0/8 (0) | 2/42 (5) | – | .398 |
| Ascending colon, n = 130 | 14/18 (78) | 32/62 (52) | – | .042 |
| Transverse colon, n = 71 | 32/38 (84) | 15/33 (46) | – | < .001 |
| Descending colon, n = 13 | 6/7 (86) | 4/6 (67) | – | .415 |
| Sigmoid colon, n = 60 | 32/42 (76) | 2/10 (20) | 6/8 (75) |
< .001
|
| Rectum, n = 74 | 33/41 (80) | 5/10 (50) | 20/23 (87) |
.059
|
PCF-H290TI vs. conventional colonoscope
PCF-H290TI vs. conventional gastroscope
Fig. 2 Changes in the retroflexion rate when using the PCF-H290TI. Although the retroflexion rate was only 34 % (53/154) with the conventional colonoscope on the evaluating colonoscopy, the rate improved to 76 % (117/154) with the PCF-H290TI during ESD.
Retroflexion improvement using the PCF-H290TI.
| Location | Retroflexion ability |
Retroflexion improvement
| |
| PCF-H290TI for ESD | Conventional scope on evaluating colonoscopy | ||
| Total, n-154 | 117 (76) | 53 (34) | 64/101 (63) |
| Cecum, n = 8 | 0 (0) | 0 (0) | – |
| Ascending colon, n = 18 | 14 (78) | 6 (33) | 8/12 (67) |
| Transverse colon, n = 38 | 32 (84) | 6 (16) | 26/32 (81) |
| Descending colon, n = 7 | 6 (86) | 0 (0) | 6/7 (86) |
| Sigmoid colon, n = 42 | 32 (76) | 16 (38) | 16/26 (62) |
| Rectum, n = 41 | 33 (80) | 25 (61) | 8/16 (50) |
The cases wherein it was not possible to perform retroflexion using the conventional colonoscope, but was possible using the PCF-H290TI
Outcomes related to ESD in the left-sided colon using the PCF-H290TI and the conventional colonoscope after propensity score matching.
| Variables | PCF-H290TI n = 75 | Conventional scope n = 75 |
|
| Tumor size, mm, mean ± SD | 30 ± 15 | 31 ± 15 | .637 |
| Growth type | 1.000 | ||
LST-G | 19 (25) | 19 (25) | |
LST-NG | 43 (57) | 43 (57) | |
Polypoid | 13 (17) | 13 (17) | |
| Submucosal fibrosis | .880 | ||
None | 18 (24) | 20 (27) | |
Mild | 37 (49) | 34 (45) | |
Severe | 20 (27) | 21 (28) | |
| Retroflexion ability | 50 (67) | 36 (48) | .020 |
| Endoscope operability | < .0001 | ||
Good | 25 (33) | 8 (11) | |
Intermediate | 17 (23) | 42 (56) | |
Poor | 33 (44) | 25 (33) | |
| Procedure time, min, mean±SD | 80 ± 63 | 71 ± 52 | .482 |
| Dissection speed, mm 2 /min, mean±SD | 22 ± 13 | 21 ± 12 | .396 |
| En bloc resection | 75 (100) | 74 (99) | .238 |
| Histological complete resection | 71 (95) | 73 (97) | .400 |
| Postoperative bleeding | 1 (1) | 4 (5) | .158 |
| Intraoperative perforation | 4 (5) | 2 (3) | .400 |
| Histology | .786 | ||
Dysplasia | 31 (41) | 33 (44) | |
Tis carcinoma | 31 (41) | 27 (36) | |
T1 carcinoma | 13 (17) | 15 (20) |
LST-G, laterally spreading tumor granular type; LST-NG, laterally spreading tumor non-granular type; SD, standard deviation
Outcomes related to ESD in the left-sided colon using the PCF-H290TI with retroflexion and the conventional colonoscope without retroflexion after propensity score matching.
| Variables | PCF-H290TI with retroflexion | Conventional scope without retroflexion |
|
| Tumor size, mm, mean ± SD | 27 ± 9 | 27 ± 9 | .849 |
| Growth type | .824 | ||
LST-G | 9 (27) | 7 (21) | |
LST-NG | 20 (61) | 21 (64) | |
Polypoid | 4 (12) | 5 (15) | |
| Submucosal fibrosis | .791 | ||
None | 12 (36) | 12 (36) | |
Mild | 14 (42) | 16 (48) | |
Severe | 7 (21) | 5 (15) | |
| Endoscope operability | .012 | ||
Good | 16 (48) | 5 (15) | |
Intermediate | 7 (21) | 13 (39) | |
Poor | 10 (30) | 15 (45) | |
| Procedure time, min, mean ± SD | 61 ± 31 | 58 ± 25 | .964 |
| Dissection speed, mm 2 /min, mean ± SD | 25 ± 12 | 19 ± 13 | .011 |
| En bloc resection | 33 (100) | 32 (97) | .236 |
| Histological complete resection | 31 (94) | 31 (94) | 1.00 |
| Postoperative bleeding | 0 (0) | 2 (6) | .092 |
| Intraoperative perforation | 2 (6) | 0 (0) | .092 |
| Histology | .936 | ||
Dysplasia | 15 (45) | 15 (45) | |
Tis carcinoma | 12 (36) | 13 (39) | |
T1 carcinoma | 6 (18) | 5 (15) |
LST-G, laterally spreading tumor granular type; LST-NG, laterally spreading tumor non-granular type; SD, standard deviation